发明名称 CRYSTALLINE FORM OF AN INHIBITOR OF MDM2/4 AND P53 INTERACTION
摘要 <p>A crystalline form of (S)-1-(4-Chloro-phenyl)-7-isopropoxy-6-methoxy-2-(4-{methyl-[4-(4-methyl-3-oxo-piperazin-1-yl)-trans-cyclohexylmethyl]-amino}-phenyl)-1,4-dihydro-2H-isoquinolin-3-one, which is useful in the treatment of a disease or disorder associated with the interaction between p53, or variants thereof, and MDM2 and/or MDM4, or variants thereof, respectively.</p>
申请公布号 SI2640467(T1) 申请公布日期 2015.04.30
申请号 SI20110030417T 申请日期 2011.11.17
申请人 NOVARTIS AG 发明人 BERGHAUSEN JOERG;REN HAIXIA
分类号 主分类号
代理机构 代理人
主权项
地址